Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| 2017/0340689 |
TITRATED EXTRACTS OF CYNARA SCOLYMUS FOR USE IN THE TREATMENT OF
MESOTHELIOMA The present invention relates to a titrated extract of Cynara scolymus, to titrated fractions of extract of Cynara scolymus or titrated mixtures of said... |
| 2017/0340688 |
TITRATED EXTRACTS OF CYNARA SCOLYMUS AND USES THEREOF The present invention relates to a titrated extract of Cynara scolymus, to titrated fractions of extract of Cynara scolymus or titrated mixtures of said... |
| 2017/0340687 |
NOVEL GENETICALLY ENGINEERED VACCINIA VIRUSES The present invention provides a genetically recombinant vaccinia virus effective in preventing or treating cancer. Specifically, the present invention... |
| 2017/0340686 |
NOVEL SHIGATOXIN-PRODUCING F18 TYPE E. COLI BACTERIOPHAGE ESC-COP-1 AND
USE THEREOF FOR INHIBITING... The present invention relates to a Myoviridae bacteriophage Esc-COP-1 that is isolated from the nature and can kill specifically Shigatoxin-producing type F18... |
| 2017/0340685 |
NOVEL CLOSTRIDIUM PERFRINGENS BACTERIOPHAGE CLO-PEP-1 AND USE THEREOF FOR
INHIBITING PROLIFERATION OF... The present invention relates to a Myoviridae bacteriophage Clo-PEP-1 that is isolated from the nature and can kill Clostridium perfringens cells specifically,... |
| 2017/0340684 |
TETRAFUNCTIONAL BACTERIOPHAGE The invention provides a recombinant targeted bacteriophage for expressing a transgene in a target cell transduced with the bacteriophage. The bacteriophage... |
| 2017/0340683 |
BACILLUS SUBTILIS STRAIN WITH PROBIOTIC ACTIVITY The current invention concerns a new B. subtilis strain with strong inhibition of C. perfringens and its use as a probiotic. |
| 2017/0340682 |
BACILLUS COMPOSITIONS AND METHODS OF USE WITH RUMINANTS Bacillus strains, compositions and methods are disclosed for reducing growth of microorganisms in a feed. Bacillus strains, compositions and methods are... |
| 2017/0340681 |
USE OF STREPTOCOCCUS THERMOPHILIS TCI633 IN TREATING ARTHRITIS A method of treating arthritis, which comprising administering to a subject in need an effective amount of Streptococcus thermophilus DSM 28121 strain. The... |
| 2017/0340680 |
USE OF A PARTICULAR EXTRACT OF PROPOLIS FOR COMBATING THE SIDE EFFECTS OF
CHEMOTHERAPY The invention relates to the use of a composition comprising at least one extract of propolis, having at least one of the following properties:--an antioxidant... |
| 2017/0340679 |
ANTIVENOM COMPOSITIONS AND USES THEREOF Disclosed herein are compositions and methods for treating a victim of a venomous snakebite. Antivenom compositions are prepared from snake plasma or from... |
| 2017/0340678 |
SERUM-FREE AND XENOGEN-FREE HUMAN CARDIAC EXPLANT-DERIVED STEM CELLS AND
USES AND METHODS FOR THE PRODUCTION... Methods for generating serum-free and/or xenogen-free cardiac explant-derived stem cells (EDC) are provided. These methods may include providing an initial... |
| 2017/0340677 |
METHOD FOR PRODUCING THERAPEUTIC CORNEAL ENDOTHELIAL SUBSTITUTE CELL
SPHERE The problem of the present invention is to provide a method of efficiently producing therapeutic alternative corneal endothelial cells, particularly, a method... |
| 2017/0340676 |
CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF DIABETES AND
ASSOCIATED METABOLIC DISORDERS AND FOR... The present invention relates to a cell-based composition comprising a suspension of mesenchymal stem cells in crystalloid with a cellular concentration from... |
| 2017/0340675 |
CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF ACUTE STROKE A method for the treatment of acute stroke in a subject by administering to said subject an effective amount of a cell-based composition containing a... |
| 2017/0340674 |
PREVENTION OF PROGRESSIVE HEART FAILURE The present disclosure relates to methods for preventing progressive heart failure in subjects with persistent left ventricular (LV) dysfunction. Such methods... |
| 2017/0340673 |
LYSATES OF MESENCHYMAL STEM CELLS FOR THE TREATMENT OF SKELETAL MUSCLE
INJURIES The present invention relates to the use of the intracellular content of mesenchymal stem cells in individuals for stimulating the survival, regeneration... |
| 2017/0340672 |
CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF The present disclosure provides a heterodimeric, conditionally active chimeric antigen receptor (CAR), and a nucleic acid comprising a nucleotide sequence... |
| 2017/0340671 |
Blood Plasma and Plasma Fractions as Therapy for Tumor Growth and
Progression The invention relates to treating individuals with cancer by using blood plasma or blood plasma fractions as treatment. |
| 2017/0340670 |
CD11 B[low] MACROPHAGES AND CONDITIONED MEDIA THEREOF FOR TREATING CANCER
AND/OR FIBROSIS A conditioned cell culture medium of CD11b.sup.low human macrophages or a biologically active fraction thereof can be prepared by a method that includes (i)... |
| 2017/0340669 |
TOLEROGENIC DENDRITIC CELLS, METHODS OF PRODUCING THE SAME, AND USES
THEREOF Described herein are methods for the preparation of stable semi-mature tolerogenic dendritic cells and compositions comprising such stable semi-mature... |
| 2017/0340668 |
NOVEL PHARMACEUTICAL COMPOSITION AND USE THEREOF FOR TREATING LUNG INJURY Disclosed are a novel pharmaceutical composition and use thereof, the novel pharmaceutical composition at least comprising an effective amount of mitochondria... |
| 2017/0340667 |
COMPOSITIONS AND METHODS FOR TOPICAL TREATMENT OF TAR RESPONSIVE
DERMATOLOGICAL DISORDERS Compositions and methods for treating tar-responsive dermatological disorders are described. In particular, an anhydrous tar composition including a liquid wax... |
| 2017/0340666 |
BIOACTIVE GLASS MICROSPHERES An aluminoborate composition, an alumino-borosilicate glass composition, or a mixture thereof, and solid or hollow microspheres thereof, as defined herein.... |
| 2017/0340665 |
NANOPARTICLES AND THEIR USE IN CANCER THERAPY The present invention provides a nanoparticle comprising a core comprising a metal; and a corona comprising a plurality of ligands covalently linked to the... |
| 2017/0340664 |
Citrate Containing Beverage Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be... |
| 2017/0340663 |
MINERAL COMPLEX FORMULATIONS FOR ORAL ADMINISTRATION AND METHODS FOR THEIR
USE The invention provides an oral formulation for dietary supplementation comprising a binder and a mineral complex consisting essentially of a natural basaltic... |
| 2017/0340662 |
WEIGHT REDUCING COMPOSITION The invention relates to soft drink industry, in particular, to dietetic nutrition. The inventive weight reducing composition comprises 0.01-10 mg/l of sodium... |
| 2017/0340661 |
PATATIN-LIKE PHOSPHOLIPASE DOMAIN CONTAINING 3 (PNPLA3) iRNA COMPOSITIONS
AND METHODS OF USE THEREOF The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting the Patatin-Like Phospholipase Domain Containing 3 (PNPLA3) gene,... |
| 2017/0340660 |
Non-Reducing End Unsaturated Mannuronic Acid Oligosaccharides And
Compositions Containing Same As Active Ingredient Disclosed is a non-reducing end unsaturated mannuronic acid oligosaccharide having a molecular weight of 100-3000 Da, which is obtained by lysing... |
| 2017/0340659 |
POLYMALIC ACID-BASED NANOBIOPOLYMER COMPOSITIONS Nanobiopolymeric conjugates based on biodegradable, non-toxic and non-immunogenic poly (.beta.-L-malic acid) PMLA covalently linked to molecular modules that... |
| 2017/0340658 |
COMBINED USE OF A CHEMOTHERAPEUTIC AGENT AND A CYCLIC DINUCLEOTIDE FOR
CANCER TREATMENT A kit of parts includes a) gemcitabine or a pharmaceutically acceptable salt thereof and b) a cyclic dinucleotide or pharmaceutically acceptable salt thereof,... |
| 2017/0340657 |
PALATINOSE FOR ENHANCING DIETARY SUPPLEMENT AND PHARMACEUTICAL DELIVERY The present invention is directed to a dietary supplement comprising palatinose or a derivative thereof. The dietary supplement may be a nutritional product, a... |
| 2017/0340656 |
Non-Invasive Imaging Methods for Patient Selection for Treatment with
Nanoparticulate Therapeutic Agents Methods for providing treatment of pathologic conditions with nanoparticulate therapeutic agents are disclosed. Novel methods for determining liposomal... |
| 2017/0340655 |
ANTHRACYCLINE FORMULATIONS The invention relates to reconstituted formulations comprising an anthracycline compound, ethanol, and water. The invention also relates to injectable... |
| 2017/0340654 |
CRYSTALLINE DIFUCOSYLLACTOSE Crystalline difucosyllactose, useful in a pharmaceutical composition and a nutritional composition, is disclosed. |
| 2017/0340653 |
(R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ-
YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS... The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds... |
| 2017/0340652 |
COMBINATION THERAPY OF HSP90 INHIBITORY COMPOUNDS WITH CHK INHIBITORS A pharmaceutical composition comprising a CHK inhibitor, and an Hsp90 inhibitor according to the following formulae or tautomers, or pharmaceutically... |
| 2017/0340651 |
COMPOSITION, FORMULATIONS AND METHODS OF MAKING AND USING BOTANICALS AND
NATURAL COMPOUNDS FOR THE PROMOTION OF... The present disclosure provides compositions and formulations comprising botanicals and natural compounds for the promotion of healthy brain aging in adults... |
| 2017/0340650 |
TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, triterpenoids that... |
| 2017/0340649 |
TOPICAL AQUEOUS SPRAY COMPOSITIONS OF HALOBETASOL The present invention relates to topical aqueous spray compositions of halobetasol. The topical aqueous spray compositions may be in the form of solutions or... |
| 2017/0340648 |
Pharmaceutical Compositions Affecting Bioenergetic Processes in a
Eukaryotic Biological System and Methods of... Provided herein are methods for treating diseases and/or disorders and/or medical conditions with pharmaceutical compositions consisting of an association of... |
| 2017/0340647 |
Preservative-free Treprostinil Formulations and Methods and Devices for
Use with Same This invention provides for a unit dosage form of treprostinil at a dosage of between 0.1 mg/mL and 25 mg/mL in a sterile fluid composition formulated for... |
| 2017/0340646 |
Methods and Compositions for Decreasing Gastric Emptying Disclosed in certain embodiments is a method of decreasing gastric emptying comprising administering to a subject an effective amount of a sodium-channel... |
| 2017/0340645 |
COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES A pharmaceutical composition comprising: (a) a compound of formula 1 ##STR00001## wherein: n is 1 or 2; R.sup.1 is hydrogen, halogen, C.sub.1-4-alkyl, or ... |
| 2017/0340644 |
OPHTHALMIC AQUEOUS COMPOSITION An ophthalmic aqueous composition comprises levofloxacin, a salt thereof, or a solvate thereof; dexamethasone, an ester thereof, or a salt thereof; and one or... |
| 2017/0340643 |
VASOPROTECTIVE AND CARDIOPROTECTIVE ANTIDIABETIC THERAPY The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as... |
| 2017/0340642 |
COMBINATIONS AND METHODS COMPRISING A CAPSID ASSEMBLY INHIBITOR The present disclosure is directed to capsid assembly inhibitor compositions and methods for use in the treatment of hepatitis B virus infection. |
| 2017/0340641 |
HETEROCYCLYLAMINES AS PI3K INHIBITORS The present invention provides heterocyclylamine derivatives of Formula I: ##STR00001## wherein the variables are defined herein, that modulate the activity of ... |
| 2017/0340640 |
METHANOCARBA DERIVATIVES OF PSEUDORIBOSE THAT INHIBIT ADENOSINE KINASE Adenosine kinase inhibitors, including pharmaceutical compositions containing the adenosine kinase inhibitors, and their use for preventing epilepsy and its... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.